GUBBA PHARMA IN E NEWS

Read More

CDSCO notifies four medical devices testing labs in the country to ensure quality

October 16, 2019 Gubba Pharma In E News

With the objective to effectively regulate all medical devices under Drugs and Cosmetics (D&C) Act in a phase wise manner, the Central Drugs Standard Control...

Continue Reading

Read More

USFDA red flags Lupin for significant violations at MP unit

October 9, 2019 Gubba Pharma In E News

The US health regulator has red flagged pharma firm Lupin for significant violations of the current good manufacturing practice regulations at its Mandideep facility in...

Continue Reading

Read More

Just add water: Chemists suggest a fix for insoluble drugs

October 9, 2019 Gubba Pharma In E News

Stable metal organic frameworks are prized for their ability to capture carbon dioxide or harvest atmospheric water, but U-M researchers have developed a use for...

Continue Reading

Read More

Beximco Pharma: The Bangladeshi company connecting with the US

October 9, 2019 Gubba Pharma In E News

Beximco Pharma is a manufacturer and exporter of medicines in Bangladesh and is currently the only one exporting them to the US, a commercial achievement that...

Continue Reading

Read More

NIPER, NIB and Pharmaexcil to jointly host workshop to upgrade skills of quality control professionals

October 3, 2019 Gubba Pharma In E News

In order to upgrade the skills of professionals in quality control, the National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad in collaboration with National...

Continue Reading

Read More

J&J expands Darzalex use with another first-line FDA approval

October 3, 2019 Gubba Pharma In E News

Johnson & Johnson’s multiple myeloma therapy Darzalex has received another approval, this time as a combination therapy in the first-line setting. Darzalex (daratumumab) has been...

Continue Reading

Read More

ESMO: Pfizer eyes commercial scale-up as Array colorectal cancer combo hits its marks

October 3, 2019 Gubba Pharma In E News

Positive new colorectal cancer data has Pfizer envisioning a launch for its newly acquired Array meds. And the company is getting prepared. At the European...

Continue Reading

Read More

Bayer’s pharmacovigilance teams around the world work to detect patterns of side effects,

September 25, 2019 Gubba Pharma In E News

Bayer’s pharmacovigilance teams around the world work to detect patterns of side effects, initiate action and collect the necessary information to analyze and understand them....

Continue Reading

Read More

CDSCO to transform Indian drug regulatory system into a stringent regulatory authority

September 25, 2019 Gubba Pharma In E News

Central Drugs Standard Control Organisation (CDSCO) wants to transform the Indian Regulatory System Stringent Regulatory Authority (SRA), as outlined by WHO and at par with...

Continue Reading